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Abstract
Data from the Substance Abuse and Mental Health Services Administration_s Integrated
Database (IDB) were used to examine the service use patterns of individuals with possible opiate
use disorders in Washington State. Results indicate that regardless of Medicaid enrollment status,
individuals who received mental health (MH) or substance abuse (SA) services only through state
agencies received no inpatient substance abuse service. Furthermore, when compared with
individuals who received at least one MH/SA service through Medicaid, those who received services
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Healthcare Utilization of Individuals with Opiate Use Disorders BRAY et al. 91only through the state agencies were less likely to have received any MH services and were more
likely to have received residential SA services. This analysis highlights the importance of using
integrated client data in providing a more comprehensive understanding of services to inform policy
and raises signiﬁcant questions about how regulatory requirements affecting different funding
mechanisms might drive settings of care in ways not related to the care needed.
Introduction
The use of, abuse of, and dependence on opiates is a major public health concern.
1,2 Although
only about 0.1% of the U.S. population reported past-year heroin use in 1998,
3 heroin and
other opiate use accounted for about 30% of total spending for illicit drug use treatment and
almost 18% of spending on drug-related crime.
4 Psychological and physical health problems
were also common among heroin and other opiate users in the mid- to late-1990s.
5 As recently
as 2003, heroin accounted for 23% of the mentions of substances used among emergency room
patients and 41% of drug-related deaths recorded by medical examiners or coroners.
6 The
social costs of opiate abuse are not limited to illegal drugs. A recent study suggests that in 2001,
the social cost of prescription opioid abuse in the United States was $8.6 billion.
7
Despite the overwhelming societal costs associated with opiate use disorders, few studies
have investigated the substance abuse (SA) or mental health (MH) treatment service patterns
of individuals suffering from opiate abuse or dependence; rather, most studies focus almost
exclusively on those in methadone maintenance treatment.
8–10 These studies suggest that the
co-occurrence of MH problems and other illicit drug dependence is quite high among
individuals with an opiate use disorder.
11–13 Yet, despite the increased incidence of MH
conditions, individuals with a substance use disorder may not receive adequate levels of MH care
beyond that directly related to their substance use disorder.
10,11,14,15 Given these ﬁndings and the
major public health concerns caused by opiate abuse and dependence, the lack of information
about the broader MH/SA treatment service patterns of individuals with an opiate use disorder
is a critical gap in the knowledge base informing policies affecting this population.
This study used data from the Substance Abuse and Mental Health Services Administration_s
(SAMHSA) Integrated Database (IDB) on individuals in Washington State with anindication of
an opiate use disorder to determine what MH/SA services they received and through which
auspice (i.e., Medicaid or state agency) they received them. Findings from this study offer two
contributions to the current literature. First, the IDB presents a unique opportunity to study the
behavioral health care utilization of individuals with opiate use disorders because it contains
service use data linked at the client level from Washington Medicaid and from the Washington
State Department of Social and Health Services_ (DSHS) Mental Health Division (MHD) and
Division of Alcohol and Substance Abuse (DASA). The combination of Medicaid and DSHS
data represented in the IDB provides a more comprehensive picture of service use patterns than
might be obtained from studies thatfocus on only one data source.Second, the late 1990s is often
characterized as a time of a heroin epidemic in the United States.
16 Therefore, examining the
MH/SA treatment service use patterns of individuals with opiate use disorders during this
period can provide an especially relevant baseline for today_s policy makers as they attempt to
address issues surrounding the emergence of new opiates.
Data and Methods
This paper uses IDB data on Washington State from three full calendar years (1996–1998).
For a more detailed description of the IDB, see Coffey et al.,
17 and for a detailed description
of the methods used to link IDB service records across state organizations, see Whalen et al.
18
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demographics (e.g., age, gender, race/ethnicity), Medicaid enrollment status, MH/SA
diagnosis and service codes, and limited provider information.
Study population
The study population for this analysis consists of individuals who have at least one record
in the IDB indicating an opiate use disorder. An opiate use disorder could be indicated by
one or more of the following: a diagnosis (either primary or secondary) of an opiate use
disorder, a provider type indicative of opiate treatment, a service or procedure code
indicative of opiate treatment (including methadone maintenance therapy but excluding
methadone used for pain management), or a report of an opioid as the drug of choice.
Opiate use disorder diagnoses were deﬁned using the International Classiﬁcation of Diseases,
9th Revision, Clinical Modiﬁcation (ICD-9-CM). ICD-9-CM codes of 304.0 or 305.5,
including any subclassiﬁcations, were used to identify opiate dependence and abuse,
respectively. State-speciﬁc provider codes were used to identify opiate treatment providers.
Both standard [e.g., Healthcare Common Procedure Coding System (HCPCS)] and local
procedure codes were used to identify opiate treatment services. Finally, drug-of-choice
information was available from self-reports obtained by state agencies during client intake.
In some cases, the drug-of-choice information was obtained more than 1 year before or after
any SA or MH service provision, but these cases represent less than 3% of the sample.
Preliminary analyses revealed that very few agency service records include diagnosis codes,
but most Medicaid records do. Further investigation revealed that this is not an issue of
Medicaid requiring a diagnosis for eligibility, but rather an issue of the data systems
themselves. Agency services do not require a diagnosis code for reimbursement, so agency
data systems do not track diagnosis. Conversely, Medicaid services often require a diagnosis
for reimbursement, so Medicaid data systems track diagnosis. Because the presence or
absence of a diagnosis is almost completely confounded by the use or nonuse of Medicaid
services, information on service use differences associated with an opiate use disorder
diagnosis is not presented.
Client classiﬁcation
One of the primary objectives of this study was to examine the extent to which the MH/SA
service use patterns of individuals with an opiate use disorder varied based on whether their
MH/SA services were tracked by Medicaid or a state MH/SA agency. Importantly, service
tracking may, or may not, be associated with full or partial ﬁnancial coverage. Accordingly,
for this study, individuals were classiﬁed based on the data source (Medicaid or state MH/
SA agency) from which their IDB MH/SA service records were obtained. Based on this
information, individuals were classiﬁed into three categories:
  Any Medicaid service: individuals who have at least one Medicaid MH/SA service record,
regardless of whether they have MH/SA state agency service records
  Agency services only with Medicaid enrollment: individuals who have at least one MH/SA
state agency service record and were Medicaid-enrolled at some point between their ﬁrst
and last observed MH/SA service record but have no record of receiving an MH/SA
service through Medicaid
  Agency services only without Medicaid enrollment: individuals who have at least one MH/
SA state agency service record and were not Medicaid-enrolled at any time between their
ﬁrst and last observed MH/SA service record
Healthcare Utilization of Individuals with Opiate Use Disorders BRAY et al. 93Because the IDB integrates information from state Medicaid and state MH/SA agency
data sources, overlapping records may occur if Medicaid reimburses a bill, but the state agency
provides the service. To avoid overstating utilization rates, only one service date was counted
for cases in which the same client, service type (MH or SA), modality/setting of service [i.e.,
inpatient (IP), residential/long-term care, or outpatient (OP)], and service date were reported
on both the Medicaid and state agency databases. Individuals with these types of records were
classiﬁed as any Medicaid service. Importantly, although individuals in the any Medicaid service
group may have received any number, or even the majority, of their services through the state
agency, preliminary analyses indicated that individuals who received both Medicaid and
agency services were more similar to those who received only Medicaid services than they were
to those who received only agency services. For this reason, individuals receiving any Medicaid
service were combined into a single category.
In addition to the client categorization described above, the standard IDB client
classiﬁcation was also used. The IDB client classiﬁcation was used to identify individuals
who received services for only MH conditions (MH-only), only SA conditions (SA-only), or
co-occurring conditions (both MH and SA) during the study period. The IDB classiﬁes
individualsashavingco-occurringconditionsiftheyhadany ofthe followingwithin the3-year
study period: (1) both a primary MH and a SA diagnosis, (2) a primary MH and a secondary
SA diagnosis, or (3) a primary SA and a secondary MH diagnosis. Individuals classiﬁed as
having co-occurring conditions did not necessarily have MH and SA conditions concurrently.
A client with an MH record at the beginningof the study period and an SA record at the end of
thestudy period, forexample,isclassiﬁed bytheIDB ashavingco-occurring conditions. In the
absence of diagnosis information, MH-only and SA-only classiﬁcations were assigned based
on the type of service received during the study period (see Coffey et al.
17 and Bray et al.
19 for
a detailed deﬁnition of the primary MH/SA diagnosis category).
The IDB client classiﬁcation does not incorporate information on secondary diagnoses
unless a primary MH/SA diagnosis is also present, nor does it incorporate drug-of-choice
information from state agency intake records. Because both of these pieces of information
were used to identify individuals with an opiate use disorder for this study, it is possible for
individuals with an opiate use disorder to be classiﬁed as MH-only or having received no
MH/SA service based on the IDB client classiﬁcation.
Service classiﬁcation
Standard IDB service type classiﬁcations were used to classify the MH/SA services
received by individuals with an opiate use disorder. The IDB MH/SA service type classiﬁes
MH/SA service records as either MH or SA and within MH/SA as IP, residential, or OP.
Many inpatient programs are part of psychiatric or general hospitals and generally use a
medical model of substance disorders in which intensive medication and counseling are
provided over a relatively short period of time.
20 Residential programs typically are provided
in a free-standing, designated residential treatment facility. Residential treatment is usually
of longer duration than IP treatment and relies less on medical professionals. Residential
treatment provides organized services by designated treatment personnel who provide a
planned regimen of care in a 24-h setting and is intended to serve clients who need a safe and
stable living environment to develop sufﬁcient recovery skills.
21 For a complete description
of the criteria used to classify services, see Coffey et al.
17 The vast majority of individuals
with a possible opiate use disorder have at least 1 SA service record, but relatively few have
MH service records; therefore, the IP, residential, and OP subclassiﬁcations were examined
for SA service records but not for MH service records.
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An individual_s total number of service encounter dates was deﬁned as the count of unique
dates within the MH/SA service window on which the individual had a record with at least one
serviceofagivenservicecategory(MH,IPSA, residentialSA, orOPSA).WithinasingleIPor
residential stay, each daily service encounter date was counted separately. Using standard IDB
deﬁnitions for the full SA population, this same information is presented for the broader SA
population, excluding individuals with an indication of an opiate use disorder.
Methods
To characterize the level of contact individuals with an opiate use disorder have with the
public treatment system, the analysis examined four key domains: (1) the proportion of
clients using services, (2) the median length of the service window (i.e., the length of time
between an individual_s ﬁrst and last MH/SA service), (3) the number of days of Medicaid
enrollment within the service window, and (4) the number of unique MH/SA encounter dates
within the service window.
Regression analyses were conducted to assess whether the service use patterns of
individuals with an opiate use disorder differed signiﬁcantly across the client classiﬁcation
categories after controlling for differences in the length of the MH/SA service window, the
length of Medicaid enrollment, and demographics across the client categories. First, logistic
regression models of the following form were estimated:
Prob SERVi ¼ 1 ðÞ ¼ f  1DEMOGi þ  2GROUPi þ  3WINDOWi þ  4ENROLLi ðÞ ;
where SERVi is a series of indicators for receipt of services of a given type. For the
regression analyses, any MH services and OP and residential SA services were considered.
Regression analyses for IP SA services were not conducted because those services were
received solely by the any Medicaid service group. DEMOGi is a set of demographic
characteristics (i.e., gender, age, and race/ethnicity); GROUPi is a vector of variables
representing the data source categories of any Medicaid service (the referent), agency services
only with Medicaid enrollment,a n dagency services only without Medicaid enrollment;
WINDOWi is the MH/SA service window length in days; and ENROLLi is the months of
Medicaid enrollment (including 0 months). The bs are vectors of coefﬁcients to be estimated.
Variables reﬂecting the primary diagnosis categories are not included because much of the
information used to classify individuals as MH-only, SA-only, or co-occurring was also used
to classify services as MH or SA.
Next, regressions of the following form were run on days of service, conditional on service use:
ln DAYSi ðÞ ¼  1DEMOGi þ  2GROUPi þ  3WINDOWi þ  4ENROLLi þ "i;
where DAYSi is a set of variables reﬂecting the unique days of care for each of the same types
of care, and all other terms are as previously deﬁned. Consistent with the recommendations of
Manning and Mullahy,
22 generalized linear model (GLM) estimation with a log link and a
gamma distribution on the natural scale was used rather than ordinary least squares (OLS) on
the log scale.
Results
Table 1 presents the demographic characteristics of the individuals identiﬁed as having an
opiate use disorder in the IDB. For a point of comparison, Table 1 also presents the same
information for the general IDB SA population, as deﬁned in Coffey et al.,
17 but excluding
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Characteristics of individuals with a possible opiate use disorder compared with the non-opiate
SA population
Population characteristic Non-opiate SA population Opiate users
All users (N) 83,793 15,652
Percentage of total
SA population (%)
84.3 15.7
Gender (%)
Male 63.2 56.8
Female 36.8 43.2
Unknown 0.0 0.0
Age (%)
Youth (0–17) 19.9 3.1
Adult (18–64) 78.8 96.5
Elderly (65+) 1.3 0.4
Unknown 0.0 0.0
Race/ethnicity (%)
White 70.0 77.6
Black 9.0 10.6
Hispanic 8.5 4.3
Native American 7.8 4.5
Other 3.6 2.6
Unknown 1.0 0.3
IDB client category (%)
SA-only 68.8 59.9
Co-occurring (MH+SA) 31.2 34.7
MH-only 0.0 1.9
Neither MH nor SA 0.0 3.4
MH/SA service type (%)
SA services (%)
Any setting 94.9 94.6
Inpatient 3.0 6.2
Residential 31.9 57.7
Outpatient 80.9 71.4
No SA services 5.1 5.4
Any MH service 31.2 36.5
MH/SA service window length
25th percentile (days) 38.0 78.0
Median (days) 168.0 348.0
75th percentile (days) 446.0 770.0
MH/SA service data source (%)
Any Medicaid 46.0 51.0
Agency services only with
Medicaid enrollment
17.3 22.7
Agency services only without
Medicaid enrollment
36.8 26.3
SA Substance abuse, MH mental health
96 The Journal of Behavioral Health Services & Research 35:1 January 2008individuals with an opiate use disorder. Individuals with an opiate use disorder accounted
for approximately 16% of the population with any SA disorder. In terms of demographics,
when compared with individuals with a non-opiate SA disorder, individuals with an opiate
use disorder are less likely to be male and more likely to be adults (as opposed to youth or
elderly), but only minor differences in the distribution of clients across racial/ethnic
categories are observed. Individuals with an opiate use disorder are less likely to be in the
SA-only IDB client classiﬁcation category. This is largely by construction because as
discussed earlier, the current paper uses more inclusive data to identify individuals with a
possible opiate use disorder than is used by the IDB client classiﬁcation. Individuals with an
opiate use disorder were more likely to have IP and residential SA services than the general
SA population, but less likely to have any OP SA service. Individuals with an opiate use
disorder were also more likely to have received any MH service compared to the general SA
population. They also had longer MH/SA service windows, indicating longer periods of
contact with the public MH/SA treatment system, and were more likely to be in the any
Medicaid service and the agency services only with Medicaid enrollment groups.
Figure 1 presents the median MH/SA service window and length of Medicaid enrollment
across individuals with a possible opiate use disorder in each of the data source categories.
The any Medicaid service group has the longest median MH/SA service window and the most
median days of Medicaid enrollment within that window, followed by the agency services
Figure 1
Median MH/SA service window length and days of medicaid enrollment among individuals
with a possible opiate use disorder by data source category
Healthcare Utilization of Individuals with Opiate Use Disorders BRAY et al. 97only with Medicaid enrollment group and then the agency services only without Medicaid
enrollment group. Because the analysis only examines Medicaid enrollment within the MH/
SA service window, the length of Medicaid enrollment is always less than the total service
window length. The total Medicaid enrollment of an individual may be greater than that
reported here, but by deﬁnition of the service window, no MH/SA service use occurred
during days of Medicaid enrollment not captured by this measure. Importantly, the any
Medicaid service group may have received substantial services from MH or SA state agencies,
because individuals in this group are categorized as any Medicaid service only because they
received at least one Medicaid service.
Figures 2 and 3 present the probability of service use and the median days of service
conditional on service utilization for each of the data source categories. IP SA care was not
included in Figures 2 and 3 because only individuals in the any Medicaid service group had IP
SA utilization (the conditional median days of IP SA care for that group were 6). Figure 2
suggests that the two agency services only groups are more likely to receive residential SA
services and are less likely to receive OP SA services or MH services. Conditional on receipt
of services, Figure 3 suggests that the agency services only with Medicaid enrollment group
received the most days of residential SA service, the agency services only without Medicaid
enrollment group received the most days of OP SA care, and the any Medicaid services group
received the most days of MH care.
Figure 2
Percentage of individuals with a possible opiate use disorder using MH/SA services by
service type and data source category
98 The Journal of Behavioral Health Services & Research 35:1 January 2008Table 2 presents results from the logistic regressions, including logit coefﬁcients, their
standard errors, and associated odds ratios (ORs) for the data source grouping variables.
For all other covariates, only the estimated logit coefﬁcients and their standard errors are
presented. Table 2 shows that even after controlling for the longer service window and more
months of Medicaid enrollment, the pattern observed in Figure 2 still holds. Compared with
individuals in the any Medicaid service group, individuals in the agency services only with
Medicaid enrollment and the agency services only without Medicaid enrollment groups had
signiﬁcantly higher odds of receiving at least residential SA service (OR=2.941 and
OR=1.376, respectively) and lower odds of receiving any OP SA (OR=0.311 and
OR=0.162, respectively) or any MH service (OR=0.217 and OR=0.110, respectively).
Brieﬂy examining the results for the control variables in the regression, females are
signiﬁcantly less likely to receive residential SA services. The racial/ethnic categories that are
statistically signiﬁcant suggest that racial/ethnic minorities are less likely than non-Hispanic
whites to receive services of any type. Age categories reﬂecting individuals both younger and
older than the referent of 36 to 40 were also, in general, less likely to receive services of any
type when the associated coefﬁcients were statistically signiﬁcant. The exception is that
individuals aged 21 to 35 with an opiate use disorder were more likely to receive residential
SA services. Results with regard to demographic characteristics, especially race/ethnicity,
should not be interpreted as evidence of disparities, however. Rather, they indicate the
differential representation of demographic groups across the data and highlight the
Figure 3
Median days of care conditional on service use among individuals with a possible opiate use
disorder by service type and data source category
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Healthcare Utilization of Individuals with Opiate Use Disorders BRAY et al. 101importance of controlling for those factors when assessing statistical signiﬁcance. Unexpect-
edly, months of Medicaid enrollment are positively associated with a greater likelihood of
service useonly for MHservices.Forboth typesofSAcare examined,longerMedicaid enrollment
was negatively associated with the probability of service use, although the relationship was not
signiﬁcant for residential care.
Table 3 presents the regression results for days of care, conditional on having at least 1 day
of service of that type of care. Because the natural logarithm of days of care is the dependent
variable, the coefﬁcient estimates, standard errors, and associated percentage changes for the
data source categories are presented. For all other variables, only the estimated coefﬁcients
and their standard errors are presented. For residential SA care, the agency services only with
Medicaid enrollment group is signiﬁcantly associated with more days of residential SA care
(28% increase), while the agency services only without Medicaid enrollment group is
signiﬁcantly associated with fewer days of care (56% decrease). Both agency services only
groups are signiﬁcantly and positively related to OP SA days of care: an estimated 18%
increase for the agency services only with Medicaid enrollment group and an estimated 60%
increase for the agency services only without Medicaid enrollment group. Finally, the agency
services only without Medicaid enrollment group is associated with signiﬁcantly more days of
MH care than the any Medicaid service group (56% increase). Unlike in Table 2,n o
consistent pattern emerges with regard to the demographic control variables included in the
linear regression. The length of the MH/SA service window is positively and signiﬁcantly
associated with days of care. Months of Medicaid enrollment are negatively and signiﬁcantly
associated with days of residential and OP SA care, but positively and signiﬁcantly associated
with days of MH care.
Implications for Behavioral Health
This analysis examined the service use patterns of individuals with an indication of an opiate
use disorder using IDB data from Washington for the period 1996 through 1998. Among
individuals with opiate use disorders, the receipt of at least one MH/SA service through
Medicaid appears to be positively associated with IP SA service use in that only individuals
who met this condition had any record of an IP SA service. The receipt of at least one MH/SA
service through Medicaid was also positively associated with OP SA service and with MH
service use among individuals with opiate use disorders. The use of only state MH/SA agency
services, on the other hand, was positively associated with the use of residential SA services.
The ﬁndings suggest that the regulatory restrictions faced by state agencies and Medicaid
may drive observed patterns of care for individuals with opiate use disorders. Speciﬁcally, the
ﬁnding that agency-only MH/SA service use is associated with higher rates of residential
service use and with no IP SA service use is likely tied to regulatory differences between
Medicaid and the state agencies in Washington. For example, SA block grant funds, which are
a key source of funding for both DASA and MHD, could not be used for IP hospital care
during the period covered by this analysis. This restriction most likely induced state agencies to
routepatientsforwhomoutpatientcareisinsufﬁcienttoresidentialcare.Similarly,theMedicaid
InstitutionsofMentalDisordersexclusionprohibitspaymentforpsychiatricservicesreceivedby
adults in residential care facilities with more than 16 beds and so may induce providers to route
more severe patients to IP care rather than to residential care. This explanation suggests that
using administrative data to track service use patterns may be misleading because the collection
ofservicedataisdrivenbyregulatoryenvironmentsandbillingsystemsthatmaynotcapturethe
actual intensity of care given.
The results are subject to several limitations. First, although the IDB represents one of the
mostcomprehensivecross-systemdatabasesusedtoexaminethiscriticalissuetodate,itdoesnot
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104 The Journal of Behavioral Health Services & Research 35:1 January 2008capture all possible services that could be used by individuals with possible opiate use disorders
in Washington. Other possible sources include self-pay, private insurance, and the Department
of Veterans Affairs (VA) system, among others. Another important limitation common to all
administrativedatabases isthatthe actualtreatment needofthe populationstudiedisunknown,
so deﬁnitive statements cannot be made about the appropriateness of the services received.
Furthermore, because of the limited time frame of the IDB, data are unavailable for individuals
who used MH/SA services either before 1996 or after 1998. As a result, it is possible that this
study has not captured the full service use history of some individuals who appear in the
treatment system brieﬂy at the beginning or end of the study period. A ﬁnal limitation of this
study is that information on prescription drug use is not available in the agency service records
contained in the IDB and is therefore not considered in this study.
Despite these limitations, the analysis of service use patterns of individuals with possible
opiate use disorders during the late 1990s offers key implications for today_s policy makers
as they attempt to address issues surrounding the emergence of new opiates. First and
foremost, if policy makers are trying to track the service use of a small but important
segment of the overall SA population, using integrated data is a necessity. When funding for
treatment services is cut in an effort to contain costs, it is important to determine if those
services have simply been shifted to other state programs, reﬂecting little net cost savings for
states overall. The present study combines state MH/SA agency data with state Medicaid data,
butincludingadditionaldatasources(e.g.,VAorcriminaljusticesystem)wouldprovideaneven
more complete picture of service use patterns. Second, the utility of administrative data for
analyses such as these is often limited by the inﬂuence of the regulatory environment, clinical
practice patterns, and the institutional history of the data systems used. Given that state and
federal policy makers increasingly rely on administrative data to assess the performance of the
treatment system, the results clearly highlight the need to better track service provision.
SAMHSA_s IDB, therefore, represents the vanguard of a new, expansive, cross-agency
philosophy regarding administrative data sources and serves as a model for new and more
comprehensive data integration efforts.
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